3D Printing Unpeeled: BMF 510(k) & SprintRay Midas

RAPID

Share this Article

Boston Micro Fabrication (BMF) got U.S. Food and Drug Administration (FDA) 510(k) clearance for its UltraThineer micro stereolithography (PµSL) veneer solution. The company will sell the solution to dental labs making a further move into solutions and away from only selling 3D printers. The veneer is three times thinner than comparable ones and should be more comfortable to patients.

SprintRay, the end-to-end dental, materials, software and printers provider for dental, has released the Midas Digital Press 3D Printer. This has a vacuum-sealed Resin Capsule System, which provides easier handling for more viscous resins. Resins can contain up to 70% ceramic filler. The solution shows the maturity of the 3D printing market for dental where we’re seeing many solutions for many players.

Share this Article


Recent News

3D Printing Webinar and Event Roundup: May 5, 2024

3D Printing News Briefs, May 4, 2024: Inkjet Materials, 3D Printed Mac Clone, & More



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

Kings 3D Introduces Five New 3D Printers Ahead of TCT Asia

In the weeks leading up to TCT Asia, the 3D printing scene in China is already bustling with activity and product promotion. Among the companies taking part is stereolithography (SLA)...

3D Printing Webinar and Event Roundup: April 28, 2024

In this week’s 3D Printing Webinar and Event Roundup, the Ceramics Expo is taking place in Michigan, Stratasys continues its advanced training courses, and SPE is holding a Polymer Characterization...

3D Printing Webinar and Event Roundup: April 21, 2024

It’s another busy week of webinars and events, starting with Hannover Messe in Germany and continuing with Metalcasting Congress, Chinaplas, TechBlick’s Innovation Festival, and more. Stratasys continues its advanced training...

Latest Earnings Overview for Australian 3D Printing Firms Titomic and AML3D

Australian 3D printing manufacturing firms Titomic (ASX: TTT) and AML3D (ASX: AL3) reported their financial results for the period from July to December 2023, marking the first half of their...